ALLYX BOWTHORPE: Open Payments
NPI 1033509989 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 20 payments from 9 companies in 2025. Trend: 2023 $364 · 2024 $676 · 2025 $412
Food & beverage: $317Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $115 |
| ABBVIE INC. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Almirall LLC | 1 | $23 |
| Organon LLC | 3 | $18 |
| Lilly USA, LLC | 1 | $17 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: TREMFYA, COSENTYX, Zoryve, RINVOQ, LIBTAYO, SKYRIZI, DUPIXENT, Seysara.
Industry payments across UT — which companies pay providers there.
